IL17A and lung cancer: The benefits of OLP (or other polyphenolic compounds) [49] and the involvement of IL-17A in the cellular and molecular mechanisms of inflammation and lung cancer development have been investigated in many in vitro studies at high concentrations (0 to 200 mM and 0–100 ng/mL, respectively) but never reached in vivo.